Related Experiment Video
Updated: Nov 11, 2025

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
Extramedullary Multiple Myeloma with Hepatic Involvement
Manpreet Singh1, Harkirat Singh1, Phison Pham1
1Internal Medicine, St Agnes Medical Center, Fresno, USA.
Hepatic involvement in multiple myeloma (MM) is rare, presenting as space-occupying lesions. Early recognition of extramedullary multiple myeloma (EMM) in the liver is crucial for prognosis and patient management.
Area of Science:
- Hematology
- Oncology
- Hepatology
Background:
- Multiple myeloma (MM) is a plasma cell malignancy.
- Extramedullary multiple myeloma (EMM) involves plasma cell tumors outside the bone marrow.
- Hepatic involvement in MM/EMM is an uncommon but significant clinical finding.
Observation:
- Presents two distinct cases of EMM with hepatic space-occupying lesions.
- Highlights the diverse clinical presentations of liver involvement in MM.
- Hepatic lesions in EMM can mimic other liver pathologies.
Findings:
- Hepatic involvement by EMM signifies a poor prognosis.
- The clinical presentation of hepatic EMM is variable.
- Diagnosis requires integration of imaging, serology, and biopsy.
Implications:
- Early identification of hepatic EMM is essential for accurate staging.
- Recognizing hepatic EMM aids in treatment planning and prognostic assessment.
- Understanding this rare manifestation improves patient outcomes and clinical management.
More Related Videos
09:52Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
Published on: January 25, 2015
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019